1887
Rapid communication Open Access
Like 0

Abstract

The incidence of most respiratory-transmitted diseases decreased during the COVID-19 pandemic as a result of containment measures. In contrast, in the Netherlands we noted an increase in invasive disease caused by b (Hib) (from < 0.3/100,000 before 2019 to 0.39 and 0.33/100,000 in 2020 and 2021) in vaccinated and unvaccinated age groups. We did not find a change in vaccine effectiveness against Hib invasive disease (effectiveness > 90%). We discuss factors that may have contributed to this rise.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2021.26.42.2100956
2021-10-21
2021-12-01
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2021.26.42.2100956
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/26/42/eurosurv-26-42-2.html?itemId=/content/10.2807/1560-7917.ES.2021.26.42.2100956&mimeType=html&fmt=ahah

References

  1. Middeldorp M, van Lier A, van der Maas N, Veldhuijzen I, Freudenburg W, van Sorge NM, et al. Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020. Vaccine. 2021;39(7):1039-43.  https://doi.org/10.1016/j.vaccine.2020.12.080  PMID: 33478793 
  2. Brueggemann AB, Jansen van Rensburg MJ, Shaw D, McCarthy ND, Jolley KA, Maiden MCJ, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6):e360-70.  https://doi.org/10.1016/S2589-7500(21)00077-7  PMID: 34045002 
  3. Dirkx KKT, Mulder B, Post AS, Rutten MH, Swanink CMA, Wertheim HFL, et al. The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained. Int J Infect Dis. 2021;111:196-203.  https://doi.org/10.1016/j.ijid.2021.08.060  PMID: 34455081 
  4. Kelly DF, Moxon ER, Pollard AJ. Haemophilus influenzae type b conjugate vaccines. Immunology. 2004;113(2):163-74.  https://doi.org/10.1111/j.1365-2567.2004.01971.x  PMID: 15379976 
  5. Hahné S, Bollaerts K, Farrington P. Vaccination programmes. Epidemiology, monitoring, evaluation. Abingdon-on-Thames: Routledge; 2021. ISBN 9781138054851.
  6. van Lier EA, Oomen PJ, Giesbers H, van Vliet H, Hament H-M, Drijfhout IH, et al. Vaccinatiegraad en jaarverslag Rijksvaccinatieprogramma Nederland 2020. [Immunisation coverage and annual report National Immunisation Programme in the Netherlands 2020]. Bilthoven: National Institute for Public Health and the Environment; 2021. Dutch. Available from: https://www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020
  7. Ruijs WL, Hautvast JL, van der Velden K, de Vos S, Knippenberg H, Hulscher ME. Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study. BMC Public Health. 2011;11(1):102.  https://doi.org/10.1186/1471-2458-11-102  PMID: 21320348 
  8. van den Boogaard J, van der Ende A, Westerhof A, Ruijs WLM, de Melker HE, Knol MJ. Voldoen medisch microbiologische laboratoria en de GGD aan de landelijke meldingsplicht voor invasieve Hib-ziekte? [Do medical microbiological laboratories and the municipal health services comply with the national reporting obligation for invasive Hib disease?]. Infectieziekten Bulletin. 2019;30(2). Dutch. Available from: https://magazines.rivm.nl/2019/03/infectieziekten-bulletin/voldoen-medisch-microbiologische-laboratoria-en-de-ggd-aan-de
  9. Backer JA, Mollema L, Vos ER, Klinkenberg D, van der Klis FR, de Melker HE, et al. Impact of physical distancing measures against COVID-19 on contacts and mixing patterns: repeated cross-sectional surveys, the Netherlands, 2016-17, April 2020 and June 2020. Euro Surveill. 2021;26(8).  https://doi.org/10.2807/1560-7917.ES.2021.26.8.2000994  PMID: 33632374 
  10. Vermeer P, Kregting J. Religion and the transmission of COVID-19 in the Netherlands. Religions (Basel). 2020;11(8):393.  https://doi.org/10.3390/rel11080393 
  11. Giufrè M, Daprai L, Cardines R, Bernaschi P, Ravà L, Accogli M, et al. Carriage of Haemophilus influenzae in the oropharynx of young children and molecular epidemiology of the isolates after fifteen years of H. influenzae type b vaccination in Italy. Vaccine. 2015;33(46):6227-34.  https://doi.org/10.1016/j.vaccine.2015.09.082  PMID: 26440924 
  12. Shrestha S, Stockdale LK, Gautam MC, Gurung M, Feng S, Maskey P, et al. Impact of vaccination on haemophilus influenzae type b carriage in healthy children less than 5 years of age in an urban population in Nepal. J Infect Dis. 2021;224(Supplement_3) Supplement_3;S267-74.  https://doi.org/10.1093/infdis/jiab072  PMID: 34469554 
  13. Schurink-van ’t Klooster TM, de Melker HE, editors. The National Immunisation Programme in the Netherlands. Surveillance and developments in 2019-2020. Bilthoven: National Institute for Public Health and the Environment; 2020. Available from: https://www.rivm.nl/bibliotheek/rapporten/2020-0077.pdf
  14. Knuf M, Haas H, Garcia-Corbeira P, Turriani E, Mukherjee P, Janssens W, et al. Hexavalent vaccines: What can we learn from head-to-head studies? Vaccine. 2021;39(41):6025-36.  https://doi.org/10.1016/j.vaccine.2021.08.086  PMID: 34531081 
  15. Hong E, Terrade A, Denizon M, Aouiti-Trabelsi M, Falguières M, Taha MK, et al. Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules. BMC Infect Dis. 2021;21(1):715.  https://doi.org/10.1186/s12879-021-06440-w  PMID: 34330228 
  16. Monge S, Hahné SJ, de Melker HE, Sanders EA, van der Ende A, Knol MJ. Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study. Lancet Infect Dis. 2018;18(7):749-57.  https://doi.org/10.1016/S1473-3099(18)30166-X  PMID: 29752131 
/content/10.2807/1560-7917.ES.2021.26.42.2100956
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error